Sign in

CIK 0001478320 · Large accelerated filer

Adaptive Biotechnologies Corp

Sign in to watch
Ticker
ADPT
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
WA
Entity type
operating
EIN
270907024
Phone
206-659-0067
Business address
1165 EASTLAKE AVE E, SEATTLE, WA, 98109
Former names
Adaptive TCR Corp
  1. 4 Grant or award Chief People Officer acquired 44,063 shares (grant or award)
  2. 4 Grant or award Chief Commercial Officer, MRD acquired 121,875 shares (grant or award)
  3. 4 Grant or award Chief Commercial Ofc Imm Med acquired 39,063 shares (grant or award)
  4. 4 Grant or award President and COO acquired 81,250 shares (grant or award)
  5. 4 Grant or award Chief Scientific Officer acquired 837,033 shares (grant or award)
  6. 4 Grant or award Chief Financial Officer acquired 61,875 shares (grant or award)
  7. 4 Grant or award Director acquired 15,625 shares (grant or award)
  8. 4 Grant or award Director acquired 15,625 shares (grant or award)
  9. 4 Grant or award CEO and Chairman acquired 837,033 shares (grant or award)
  10. 4 Planned sale Director sold 48,044 shares at $15.30 ($735,073)
  11. 4 Planned sale President and COO sold 92,823 shares at an average $16.09 ($1,493,428)
  12. 4 Planned sale Chief Scientific Officer sold 24,233 shares at an average $16.19 ($392,329)
  13. 4 Planned sale CEO and Chairman sold 524,998 shares at an average $15.85 ($8,320,613)
  14. 144 Insider Sale of Securities
  15. 144 Insider Sale of Securities
  16. 144 Insider Sale of Securities
  17. 144 Insider Sale of Securities
  18. 144 Insider Sale of Securities
  19. 144 Insider Sale of Securities
  20. S-8 Other Securities Offered to Employees in Benefit Plans

Page 7 of 42 · 836 filings